Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,734 | 48,070 | 54,547 | 65,594 | 66,920 |
| Marketable Securities | 6,984 | 6,973 | 6,981 | 6,790 | 6,677 |
| Receivables | 47,002 | 48,821 | 44,077 | 42,032 | 24,595 |
| Inventories | 65,414 | 61,678 | 62,780 | 63,609 | 69,640 |
| TOTAL | $194,804 | $169,946 | $174,046 | $187,778 | $176,492 |
| Non-Current Assets | |||||
| PPE Net | 202,526 | 198,241 | 191,915 | 180,545 | 173,046 |
| Other Non-Current Assets | 83,312 | 83,459 | 83,821 | 82,749 | 88,228 |
| TOTAL | $285,838 | $281,700 | $275,736 | $263,294 | $261,274 |
| Total Assets | $480,642 | $451,646 | $449,782 | $451,072 | $437,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,592 | 18,891 | 6,061 | 6,312 | 6,212 |
| Accounts payable and accrued liabilities | 76,362 | 67,092 | 58,498 | 57,555 | 9,590 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 37,414 |
| TOTAL | $96,621 | $87,590 | $72,542 | $67,192 | $57,397 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,606 | 33,695 | 39,706 | 40,844 | 42,232 |
| Other Non-Current Liabilities | 9,615 | 8,510 | 9,005 | 7,939 | 4,681 |
| TOTAL | $42,751 | $43,530 | $50,136 | $50,144 | $49,714 |
| Total Liabilities | $139,372 | $131,120 | $122,678 | $117,336 | $107,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,098 | 46,256 | 46,614 | 46,351 | 45,976 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | 65,618 | 66,780 | 69,570 | 72,642 | 74,767 |
| Other shareholders' equity | 18,382 | -3,616 | -1,136 | -1,802 | -2,325 |
| TOTAL | $341,270 | $320,526 | $327,104 | $333,736 | $330,655 |
| Total Liabilities And Equity | $480,642 | $451,646 | $449,782 | $451,072 | $437,766 |